Tristan M. Sissung
National Institutes of Health(US)National Cancer Institute(US)Center for Cancer Research(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Chronic Myeloid Leukemia Treatments, PARP inhibition in cancer therapy, Drug Transport and Resistance Mechanisms, Cancer therapeutics and mechanisms
Most-Cited Works
- → Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma(2015)309 cited
- → Effect of SLCO1B3 Haplotype on Testosterone Transport and Clinical Outcome in Caucasian Patients with Androgen-Independent Prostatic Cancer(2008)190 cited
- → Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses(2014)183 cited
- → Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia(2006)169 cited
- → The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors(2009)167 cited
- → Effect of ABCG2 genotype on the oral vioavailability of topotecan(2005)160 cited